Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
March 3, 2004
FDG-PET: procedure guidelines for tumour imaging
Emilio Bombardieri, Cumali Aktolun, Richard P Baum, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2008
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop
Pier Luigi Zinzani, Francesco d'Amore, Emilio Bombardieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation
Liliana Devizzi, Anna Guidetti, Corrado Tarella, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 13, 2010
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
Emilio Bombardieri, Valentina Ambrosini, Cumali Aktolun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 12, 2012
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies
Paola A Erba, Martina Sollini, Enrico Orciuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2006
Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival
Natale Cascinelli, Emilio Bombardieri, Rosaria Bufalino, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
July 14, 2007
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results
Carlo Chiesa, Francesca Botta, Erika Di Betta, et al.
European Journal of Radiology
|
March 4, 2021
Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcome
Enzo Angeli, Serena Dalto, Stefano Marchese, et al.
Plos One
|
July 2, 2021
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
Serena Marchi, Simonetta Viviani, Edmond J Remarque, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 19, 2007
Sentinel node in breast cancer procedural guidelines
John Buscombe, Giovanni Paganelli, Zeynep E Burak, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
European Journal of Nuclear Medicine and Molecular Imaging
|
March 3, 2004
FDG-PET: procedure guidelines for tumour imaging
Emilio Bombardieri, Cumali Aktolun, Richard P Baum, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2008
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop
Pier Luigi Zinzani, Francesco d'Amore, Emilio Bombardieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation
Liliana Devizzi, Anna Guidetti, Corrado Tarella, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 13, 2010
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
Emilio Bombardieri, Valentina Ambrosini, Cumali Aktolun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 12, 2012
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies
Paola A Erba, Martina Sollini, Enrico Orciuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2006
Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival
Natale Cascinelli, Emilio Bombardieri, Rosaria Bufalino, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
July 14, 2007
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results
Carlo Chiesa, Francesca Botta, Erika Di Betta, et al.
European Journal of Radiology
|
March 4, 2021
Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcome
Enzo Angeli, Serena Dalto, Stefano Marchese, et al.
Plos One
|
July 2, 2021
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
Serena Marchi, Simonetta Viviani, Edmond J Remarque, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 19, 2007
Sentinel node in breast cancer procedural guidelines
John Buscombe, Giovanni Paganelli, Zeynep E Burak, et al.
Page
of 9